Form 4: QuidelOrtho Director Matthew Strobeck Reports Stock Transactions
SEC Form 4 Filing
Director Matthew Strobeck reports the release of restricted stock units and adjustments to beneficial ownership of QuidelOrtho Corp shares.
Summary
- On May 24, 2024, Matthew Strobeck, a director of QuidelOrtho Corp, reported transactions involving the company's common stock.
- Strobeck released 2,416 restricted stock units, which converted into common stock.
- These restricted stock units vested on May 24, 2024.
- Following these transactions, Strobeck directly owns 12,846 shares of common stock.
- Strobeck also has indirect ownership through a UGMA account holding 16,630 shares for his children and 38,145 shares held by Birchview Fund, LLC.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It's a standard practice for directors and officers to report changes in their beneficial ownership of company stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the stock transactions of a company director.
- It helps stakeholders understand the alignment of interests between management and shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/24/2024 | Date of transaction and vesting of restricted stock units. |
| 05/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.